期刊文献+

拉米夫定与HBV-YMDD变异关系的研究 被引量:1

Effect of lamizodine on the variation of HBV-YMDD
下载PDF
导出
摘要 目的探讨惠州地区慢乙肝(CHB)患者拉米夫定治疗与HBV-YMDD变异的发生和发展的关系。方法选取在肝病专科就诊的176例CHB患者,在服用拉米夫定前及服药后每半年进行HBV-DNA定量及YMDD变异检测,并选取35份发生YMDD变异和10份野生型YMDD血清样本进行DNA测序。结果176例CHB患者样本中,拉米夫定治疗前检出YMDD变异7例(其中YM/YVDD型2例、YVDD型3例、YIDD型2例),变异率3.98%;治疗2年后共检出62例(其中YVDD型9例、YIDD型36例、YM/YVDD混合型9例、YM/YIDD混合型3例、YV/YIDD混合型5例),变异率35.23%。6例CHB患者在拉米夫定治疗过程中其YMDD变异类型会发生改变。结论惠州地区CHB患者经拉米夫定治疗,随着病情发展,变异类型可能会发生改变,YIDD可能是最终的变异类型,YM/YVDD、YVDD和YM/YIDD可能都是过渡的变异类型。 Objective To investigate the correlation of lamivodine with the occurrence and development of HBV - YMDD mutation in chronic hepatitis B(CHB) in Huizhou. Methods There 176 patients from the specialized outpatient service in our hospital received lamivodine treatment and HBV - DNA and YMDD mutation were analyzed before and after treatment for six months. DNA were sequenced with 35 serum samples of YADD mutation and 10 serum samples of wild mutation. Results Out of the 176 serum samples, YMDD mutation was observed in 7 samples (2 samples were YM/YVDD, 3 samples were YVDD, 2 samples were YIDD) with a mutation rate of 3.98% ; YMDD mutation were detected in 62 samples a year after treatment (9 samples were YVDD, 36 samples were YIDD, 9 samples were YM/YVDD, 3 samples were YM/YIDD, 5 samples were YM/YVDD) with a mutation ra te of 35.20%. Among 3 patients with YM/YVDD two years after treatment, 2 patients changed to YVDD and a patient changed to YV/YIDD. 2 patients with YVDD were detected a years after treatment, but one patient changed to YIDD and another changed to YV/YIDD two years after treatment. One patient with YVDD was detected with treatment for six months, but changed to YIDD a year after treatment . Conclusion In CHB patients before Lamivodine treatment, the rate of HBV YMDD mutation was 3.98% and 35.20% two years after treatment, the type of mutation may possibly change with development of the disease, YIDD may be the final mutation type, YM/YVDD, YVDD and YM/ YIDD may be interim mutation type. The regularity of change may be YMDD→ YM/YVDD→ YVDD( YM/YIDD)→YIDD.
出处 《中国热带医学》 CAS 2008年第9期1483-1484,1487,共3页 China Tropical Medicine
基金 广东惠州市科学技术局(编号:2005Y40)
关键词 拉米夫定 慢性乙型肝炎 乙肝病毒 YMDD变异 Lamivodine Chronic hepatitis B Hepatitis B virus YMDD mutation
  • 相关文献

参考文献10

  • 1刘新钰,曹利,张汉荣.PCR熔解曲线法检测乙型肝炎病毒变异株[J].临床检验杂志,2004,22(6):445-446. 被引量:11
  • 2Atkins M, Hunt CM, Brown N, er al. Clinical significance of YMDD mutant hepatitis B virus in a large cohort of lamivudine - treated hepatitis B patients(Abstract) [J]. Hepatology, 1998,28:319A. 被引量:1
  • 3Gauthier J, Bourne EJ, Lutz MW, et al. Quantitation of hepatitis B viremia and emergence of YMDD variants in patients with chronic hepatitis B treated with lamivudine J[ J]. JinfectDis, 1999,180 : 17 - 1762. 被引量:1
  • 4颜鸣鹤,张长,凌乔,周仁芳.未经拉米夫定治疗的乙型肝炎病毒YMDD变异检测[J].中华肝脏病杂志,2003,11(7):430-431. 被引量:27
  • 5霍红,赵书民,蔡雄,缪晓辉.YMDD自然变异毒株流行病学调查[J].肝脏,2006,11(4):232-234. 被引量:16
  • 6陈发林,郭永建,伍严安,黄毅,马晓宁,黄肖利.拉米夫定治疗慢性乙型肝炎患者乙型肝炎病毒YMDD变异的研究[J].中华检验医学杂志,2006,29(11):980-983. 被引量:9
  • 7Kobayashi S, Ide T, Sata M. Detection of YMDD motif mutations in some lamivudine untreated asymptomatie hepatitis B virus carriers[ J]. J Hepatol, 2001, 34:584 - 586. 被引量:1
  • 8Zollner B, Petersen J, Puchhammer - Stockl E, et al. Viral features of lamivudine resistant hepatitis B genotypes A and D[J]. Hepatology, 2004,39:42 - 50. 被引量:1
  • 9Boucher CA, Cammack N, Schipper P, et al. High - level resistance to ( - ) enantiomeric 2' - deoxy - 3' - thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type Ⅰ reverse transcriptase [ J]. Antimicrob Agents Chemother, 1993, 37:2231 -2234. 被引量:1
  • 10Chin R, Shaw T, Torresi J, et al. In vitro susceptibilities of wild - type or drug - resistant hepatitis B virus to ( - ) - β - D - 2,6 - dia- minopurine dioxolane and 2 ' - fluoro - 5 - methyl - beta - L - arabinofuranosyluracil [ J ]. Antimicrob Agents chemother, 2001,45 : 2495 - 2501. 被引量:1

二级参考文献27

  • 1拉米夫定临床应用专家组 ,万谟彬.2004年拉米夫定临床应用专家共识[J].中华肝脏病杂志,2004,12(7):425-428. 被引量:257
  • 2王义光,朱武军,杨兴林.贵阳地区乙型肝炎病毒YMDD变异与基因分型[J].中华肝脏病杂志,2005,13(3):193-193. 被引量:17
  • 3Seta T,Yokosuka O,Imazeki F,et al.Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients.J Med Virol,2000,60:8-16. 被引量:1
  • 4Perrillo R,Hann HW,Mutimer D,et al.Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus.Gastroenterology,2004,126:81-90. 被引量:1
  • 5Sablon E,Shapiro F.Advances in molecular diagnosis of HBV infection and drug resistance.Int J Med Sci,2005,2:8-16. 被引量:1
  • 6Zhang XX,Liu CM,Gong QM,et al.Evolution of wild type and mutants of the YMDD motif of hepatitis B virus polymerase during lamivudine therapy.J Gastroenterol Hepatol,2003,18:1353-1357. 被引量:1
  • 7Kobayashi S,lde T,Sata M.Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers.J Hepatol,2001,34:584-586. 被引量:1
  • 8Chin R,Shaw T,Torresi J,et al.In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-β-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.Antimicrob Agents chemother,2001,45:2495-2501. 被引量:1
  • 9Akuta N,Suzuki F,Kobayashi M,et al.The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment.J Hepatol,2003,38:315-321. 被引量:1
  • 10侯金林,曾国兵.乙型肝炎病毒基因型与变异.中华医学会第十二次全国病毒性肝炎及肝病学术会议论文汇编.2005,37-42. 被引量:2

共引文献53

同被引文献8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部